Hemant Kulkarni1, Claire Mary Smith2, Dani Do Hyang Lee2, Robert Anthony Hirst1, Andrew J Easton3, Chris O'Callaghan2. 1. 1 Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom. 2. 2 Respiratory, Critical Care & Anaesthesia, Institute of Child Health, University College London (UCL), Great Ormond Street Hospital for Children, London, United Kingdom; and. 3. 3 School of Life Science, University of Warwick, Coventry, United Kingdom.
Abstract
RATIONALE: Respiratory syncytial virus (RSV) is a highly contagious pathogen with a huge global health impact. It is a major cause of hospital-acquired infection; a large number of those exposed develop infection. Those infected in hospital are at increased risk of a severe clinical course. Prevention of nosocomial spread currently focuses on spread by hand and large droplets. There is little research evidence to determine if aerosol spread of infectious RSV is possible. OBJECTIVES: To determine if the air surrounding infants with RSV-positive bronchiolitis contains RSV in aerosolized particles that remain capable of causing infection. METHODS: The amount of RSV contained in aerosolized particles produced by infants with bronchiolitis due to RSV was measured using viable impactor sampling. The ability of RSV contained in these particles to infect healthy and chronic obstructive pulmonary disease (COPD) human ciliated respiratory epithelium was determined. RESULTS: We showed for the first time that infants with RSV-positive bronchiolitis nursed in a ward setting or ventilated in intensive care produced large numbers of aerosol particles containing RSV that remained infectious and were capable of infecting healthy and COPD human ciliated epithelium. A significant amount of RSV was found in particles with aerodynamic diameters less than 5 μm. CONCLUSIONS: Many of the aerosolized particles that contained RSV in the air surrounding infants with bronchiolitis were sufficiently small to remain airborne for a significant length of time and small enough to be inhaled and deposited throughout the respiratory tract. It is likely that this leads to spread of infection to others, with dissemination of infection throughout the respiratory tract.
RATIONALE: Respiratory syncytial virus (RSV) is a highly contagious pathogen with a huge global health impact. It is a major cause of hospital-acquired infection; a large number of those exposed develop infection. Those infected in hospital are at increased risk of a severe clinical course. Prevention of nosocomial spread currently focuses on spread by hand and large droplets. There is little research evidence to determine if aerosol spread of infectious RSV is possible. OBJECTIVES: To determine if the air surrounding infants with RSV-positive bronchiolitis contains RSV in aerosolized particles that remain capable of causing infection. METHODS: The amount of RSV contained in aerosolized particles produced by infants with bronchiolitis due to RSV was measured using viable impactor sampling. The ability of RSV contained in these particles to infect healthy and chronic obstructive pulmonary disease (COPD) human ciliated respiratory epithelium was determined. RESULTS: We showed for the first time that infants with RSV-positive bronchiolitis nursed in a ward setting or ventilated in intensive care produced large numbers of aerosol particles containing RSV that remained infectious and were capable of infecting healthy and COPDhuman ciliated epithelium. A significant amount of RSV was found in particles with aerodynamic diameters less than 5 μm. CONCLUSIONS: Many of the aerosolized particles that contained RSV in the air surrounding infants with bronchiolitis were sufficiently small to remain airborne for a significant length of time and small enough to be inhaled and deposited throughout the respiratory tract. It is likely that this leads to spread of infection to others, with dissemination of infection throughout the respiratory tract.
Authors: Carmen L Charlton; Esther Babady; Christine C Ginocchio; Todd F Hatchette; Robert C Jerris; Yan Li; Mike Loeffelholz; Yvette S McCarter; Melissa B Miller; Susan Novak-Weekley; Audrey N Schuetz; Yi-Wei Tang; Ray Widen; Steven J Drews Journal: Clin Microbiol Rev Date: 2018-12-12 Impact factor: 26.132
Authors: Kristi J Warren; Samantha M Simet; Jacqueline A Pavlik; Jane M DeVasure; Joseph H Sisson; Jill A Poole; Todd A Wyatt Journal: Alcohol Date: 2016-08-25 Impact factor: 2.405
Authors: M R R S van Beest; F Arpino; O Hlinka; E Sauret; N R T P van Beest; R S Humphries; G Buonanno; L Morawska; G Governatori; N Motta Journal: Atmos Pollut Res Date: 2022-06-06 Impact factor: 4.831
Authors: Gerald G Kellar; Stephen R Reeves; Kaitlyn A Barrow; Jason S Debley; Thomas N Wight; Steven F Ziegler Journal: J Immunol Date: 2020-10-23 Impact factor: 5.422
Authors: Jasmin S Kutter; Dennis de Meulder; Theo M Bestebroer; Jeroen J A van Kampen; Richard Molenkamp; Ron A M Fouchier; Jérôme O Wishaupt; Pieter L A Fraaij; Sander Herfst Journal: Antimicrob Resist Infect Control Date: 2021-06-30 Impact factor: 4.887